RE:RE:RE:Angiogenesis Foundation Publishes ResultsWhat these additional results were expected to achieve July 2023. That was before the merger which optimized the company to bring transformational products to market. Gilles has also talked about a wound healing franchise.
July 2023:
“While Ceapro has so far evolved in dermatology by providing active ingredients serving the cosmetic sector, additional expected evidence-based results from this study will not only reinforce and/or add claims to existing cosmetics formulations but should further position Ceapro in dermatology along with a pharmaceutical and medical supplies partner who will benefit from additional selling points arising from this unique research program."